Ates et al., 2021 - Google Patents
Integrated devices for non‐invasive diagnosticsAtes et al., 2021
View PDF- Document ID
- 5185426807814512001
- Author
- Ates H
- Brunauer A
- von Stetten F
- Urban G
- Güder F
- Merkoçi A
- Früh S
- Dincer C
- Publication year
- Publication venue
- Advanced Functional Materials
External Links
Snippet
Abstract “Sample‐in‐answer‐out” type integrated diagnostic devices have been widely recognized as the ultimate solution to simplify testing across healthcare systems. Such systems are equipped with advanced fluidic, mechanical, chemical, biological, and …
- 238000007374 clinical diagnostic method 0 title abstract description 18
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ates et al. | Integrated devices for non‐invasive diagnostics | |
| Apoorva et al. | Recent developments and future perspectives of microfluidics and smart technologies in wearable devices | |
| Christodouleas et al. | From point-of-care testing to eHealth diagnostic devices (eDiagnostics) | |
| Beduk et al. | Smartphone-based multiplexed biosensing tools for health monitoring | |
| Tasoglu | Toilet-based continuous health monitoring using urine | |
| Xu et al. | Wearable eye patch biosensor for noninvasive and simultaneous detection of multiple biomarkers in human tears | |
| Wang et al. | Current and emerging trends in point-of-care technology and strategies for clinical validation and implementation | |
| Green et al. | What tests could potentially be used for the screening, diagnosis and monitoring of COVID-19 and what are their advantages and disadvantages | |
| Nayak et al. | Point-of-care diagnostics: recent developments in a connected age | |
| Koh et al. | A soft, wearable microfluidic device for the capture, storage, and colorimetric sensing of sweat | |
| Romeo et al. | Smart biosensors for multiplexed and fully integrated point-of-care diagnostics | |
| JP2020128995A (en) | Biochemical/chemical assay device and method for simplified step, less sample, accelerated speed, and ease-of-use | |
| US9686395B2 (en) | Apparatus and method for point-of-collection measurement of a biomolecular reaction | |
| Martinez et al. | Simple telemedicine for developing regions: camera phones and paper-based microfluidic devices for real-time, off-site diagnosis | |
| Clark et al. | Recent advances in skin-interfaced wearable sweat sensors: opportunities for equitable personalized medicine and global health diagnostics | |
| Piro et al. | Recent advances in skin chemical sensors | |
| US9434977B2 (en) | Rapid identification of organisms in bodily fluids | |
| Waltz | After theranos | |
| Hasandka et al. | Paper and thread as media for the frugal detection of urinary tract infections (UTIs) | |
| CN110573063A (en) | Colorimetric sensor for non-invasive screening of glucose in the sweat of people with pre- and type 2 diabetes | |
| Faura et al. | Colorimetric and electrochemical screening for early detection of diabetes mellitus and diabetic retinopathy—application of sensor arrays and machine learning | |
| Yan et al. | Optical biosensing systems for a biological living body | |
| Narasimhan et al. | Bio-analysis of saliva using paper devices and colorimetric assays | |
| WO2021099677A1 (en) | Device and method for detecting of brain injury in a subject | |
| Wilkirson et al. | Lateral flow-based skin patch for rapid detection of protein biomarkers in human dermal interstitial fluid |